Full Year 2022 ALS Ltd Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: John Purtell - Macquarie Research - Analyst : Just had a couple of questions. Raj, thanks for your comments there. Just in relation to the Geochem field season, which is now underway, can you just talk to what you're currently seeing there and your expectation for obviously the next sort of 6 months, which is sort of a key period for that Commodities business?

Question: John Purtell - Macquarie Research - Analyst : And just the second question. If we go back 6 months ago, Raj, obviously, you'd highlighted various cost pressures, et cetera, and you had new capacity and supply coming on and price increases there. And it looks like you've had pretty good traction on price. But how would you characterize sort of price versus cost as we move forward over '23?

Question: John Purtell - Macquarie Research - Analyst : Got you. And just in terms of the Nuvisan acquisition, just how that's performing and just how you're accounting for that, so looks like it's proportionately consolidated there in your underlying numbers, but -- is equity accounted, but just in terms of how that's performing firstly.